DV
Daniel F Voytas
Chief Science Officer

Daniel F Voytas insider trades: Calyxt (CLXT) stock sales

Chief Science Officer, Calyxt Last trade Jan 4, 2021 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
21
Open-market trades
since 2018
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Daniel reports to the SEC

Open-market buys and sales

21 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 4, 2021CLXT↓ Sell$10K
Dec 18, 2020CLXT↓ Sell$24K
Apr 29, 2019CLXT↓ Sell$61K
Feb 25, 2019CLXT↓ Sell$64K
Feb 1, 2019CLXT↓ Sell$106K
Dec 18, 2018CLXT↓ Sell$53K
Nov 8, 2018CLXT↓ Sell$53K
Oct 9, 2018CLXT↓ Sell$57K
Sep 20, 2018CLXT↓ Sell$75K
Sep 10, 2018CLXT↓ Sell$66K
Aug 20, 2018CLXT↓ Sell$81K
Aug 8, 2018CLXT↓ Sell$71K
Jul 20, 2018CLXT↓ Sell$84K
Jul 9, 2018CLXT↓ Sell$73K
Jun 20, 2018CLXT↓ Sell$96K
Jun 15, 2018CLXT↓ Sell$147K
May 21, 2018CLXT↓ Sell$78K
May 8, 2018CLXT↓ Sell$64K
Apr 20, 2018CLXT↓ Sell$79K
Apr 9, 2018CLXT↓ Sell$59K
Mar 20, 2018CLXT↓ Sell$84K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Daniel F Voytas's insider trades

Daniel F Voytas is Chief Science Officer at Calyxt (CLXT). Since Mar 20, 2018, Daniel has reported no open-market purchases and 21 sales worth $1.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (18 filings), grants and awards (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLXT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.